Cavalli Ralph Christopher 4
4 · HEMISPHERX BIOPHARMA INC · Filed Sep 20, 2012
Insider Transaction Report
Form 4
Cavalli Ralph Christopher
VP, Quality Control
Transactions
- Other
Options to buy Common Stock
2012-09-18+30,000→ 90,000 totalExercise: $0.85From: 2012-09-18Exp: 2022-09-18→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Options are being issued in accordance with the terms of the unanimous consent of the Hemispherx Board of Directors.